Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer.
Amseian G, Figueras M, Mases J, Mengual L, Ribal MJ, Quintero K, Pages R, Ingelmo-Torres M, Roldan FL, Caratini R, Fuster D, Alcaraz A, Izquierdo L, Paredes P; Clinic Barcelona Nuclear Medicine (CBNM) Group. Amseian G, et al. EJNMMI Res. 2024 Dec 18;14(1):124. doi: 10.1186/s13550-024-01170-x. EJNMMI Res. 2024. PMID: 39694939 Free PMC article.
MRI findings in patients with psychogenic non-epileptic seizures: Prevalence, distribution, and classification of the findings. A single tertiary epilepsy center experience.
Jareno-Badenas A, Matute-González M, Pintor L, Conde-Blanco E, Carreño M, Setoain X, Pineda C, Choque-Chávez FD, Fernández T, Bargalló N, González-Ortiz S. Jareno-Badenas A, et al. Among authors: setoain x. Epilepsia Open. 2024 Dec 12. doi: 10.1002/epi4.13114. Online ahead of print. Epilepsia Open. 2024. PMID: 39665676 Free article.
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma.
Zugasti I, Tormo-Ratera M, Oliver-Caldes A, Soler-Perromat JC, Gonzalez-Calle V, Moreno DF, Cabañas V, Lopez-Muñoz N, Bartolome-Solanas A, Español-Rego M, Reguera-Ortega JL, Rosiñol L, Lopez-Corral L, Tovar N, Rodríguez-Lobato LG, Alvarez Perez RM, Varea S, Olesti E, Gomez Grande A, Frutos L, Tamayo P, Juan M, Moraleda JM, Urbano-Ispizua Á, González-Navarro EAA, Martínez-López J, Mateos MV, Tomas X, Setoain X, Fernández de Larrea C. Zugasti I, et al. Among authors: setoain x. Blood Adv. 2024 Nov 27:bloodadvances.2024014360. doi: 10.1182/bloodadvances.2024014360. Online ahead of print. Blood Adv. 2024. PMID: 39602341
Subject-based assessment of large-scale integration dynamics in epileptic brain networks: insights from the intrinsic ignition framework.
Donaire A, Padilla N, Escrichs A, Khawja M, Setoain X, Rumia J, Roldan P, Bargallo N, Boget T, Pintor L, Centeno M, Conde E, Vernet O, Buendía J, Manzanares I, Ådén U, Carreño M, Kringelbach M, Deco G. Donaire A, et al. Among authors: setoain x. Cereb Cortex. 2024 Oct 3;34(10):bhae419. doi: 10.1093/cercor/bhae419. Cereb Cortex. 2024. PMID: 39441026
Efficacy of escalating therapy with brentuximab vedotin-AVD in advanced stage Hodgkin lymphoma patients with positive interim positron emission tomography after ABVD.
Martínez C, Carcelero E, Gutiérrez A, Sancho E, Martí-Tutusaus JM, Magnano L, Mozas P, Fernández-Avilés F, Antelo MG, Setoain X, Rodríguez S, Esteve J. Martínez C, et al. Among authors: setoain x. Hematol Oncol. 2024 Sep;42(5):e3299. doi: 10.1002/hon.3299. Hematol Oncol. 2024. PMID: 39132926
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.
Mozas P, Casanueva-Eliceiry S, Rivero A, Serna Á, Simó M, Rodríguez S, Rivas-Delgado A, Nadeu F, Correa JG, Piñeyroa JA, Pérez-Valencia AI, Guinetti-Ortiz K, Gómez-Hernando M, Giné E, Delgado J, Villamor N, Campo E, Magnano L, Abrisqueta P, Setoain X, López-Guillermo A. Mozas P, et al. Among authors: setoain x. Hematol Oncol. 2024 Jan;42(1):e3235. doi: 10.1002/hon.3235. Epub 2023 Nov 9. Hematol Oncol. 2024. PMID: 37942762
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.
Martínez-Cibrián N, Ortiz-Maldonado V, Español-Rego M, Blázquez A, Cid J, Lozano M, Magnano L, Giné E, Correa JG, Mozas P, Rodríguez-Lobato LG, Rivero A, Montoro-Lorite M, Ayora P, Navarro S, Alserawan L, González-Navarro EA, Castellà M, Sánchez-Castañón M, Cabezón R, Benítez-Ribas D, Setoaín X, Rodríguez S, Brillembourg H, Varea S, Olesti E, Guillén E, Sáez-Peñataro J, de Larrea CF, López-Guillermo A, Pascal M, Urbano-Ispizua Á, Juan M, Delgado J. Martínez-Cibrián N, et al. Among authors: setoain x. Br J Haematol. 2024 Feb;204(2):525-533. doi: 10.1111/bjh.19170. Epub 2023 Oct 31. Br J Haematol. 2024. PMID: 37905734
Psychiatric and psychological assessment of Spanish patients with drug-resistant epilepsy and psychogenic nonepileptic seizures (PNES) with no response to previous treatments.
Sobregrau P, Baillès E, Carreño M, Donaire A, Boget T, Setoain X, Bargalló N, Rumià J, V Sánchez Vives M, Pintor L. Sobregrau P, et al. Among authors: setoain x. Epilepsy Behav. 2023 Aug;145:109329. doi: 10.1016/j.yebeh.2023.109329. Epub 2023 Jul 13. Epilepsy Behav. 2023. PMID: 37453292 Free article.
Testing an Adapted Auditory Verbal Learning Test Paradigm for fMRI to Lateralize Verbal Memory in Patients with Epilepsy.
Conde-Blanco E, Pariente JC, Carreño M, Boget T, Pascual-Díaz S, Centeno M, Manzanares I, Donaire A, Pintor L, Rumià J, Roldán P, Setoain X, Bargalló N. Conde-Blanco E, et al. Among authors: setoain x. AJNR Am J Neuroradiol. 2022 Oct;43(10):1445-1452. doi: 10.3174/ajnr.A7622. Epub 2022 Sep 22. AJNR Am J Neuroradiol. 2022. PMID: 36137657 Free PMC article.
98 results